BAKER BROS. ADVISORS LP - Insider Non-Derivative Transactions at Kiniksa Pharmaceuticals International, plc (KNSA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 6, 2023, BAKER BROS. ADVISORS LP's relationship to Kiniksa Pharmaceuticals International, plc (KNSA) is Director, and currently has 2,719,343 shares of Class A Common Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KNSA insiders.
Data Source: SEC.
BAKER BROS. ADVISORS LP - Insider Non-Derivative Transactions at KNSA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 7, 2023 | Acquisition -- (Class A Common Shares) | 8746 | 0 | 117726 |
| Jun 7, 2023 | Acquisition -- (Class A Common Shares) | 8746 | 0 | 2719343 |